IMMUNOME, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.94 USD | +1.36% |
|
+5.06% | +39.63% |
| May. 31 | Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target | MT |
| May. 21 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 14.80 | 27.34 | 26.62 |
| Spread/Res. | +0.95% | -45.35% | -43.88% |
| Spread/Supp. | +9.45% | +104.66% | +19.52% |
| Support | 13.65 | 7.300 | 12.50 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- IMNM Stock
- Charts Immunome, Inc.
